Cloning for Profit

When San Francisco-based Genetic Savings and Clone announced in December it had sold a cloned kitten to a Texas woman, the public seemed caught between feelings of revulsion and excitement over the idea of cloning the family pet.

Written byIvan Oransky
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Courtesy of Victor Fisher/Polaris

Genetic Savings and Clone's cat manager, Leslie Ungerer and CEO Lou Hawthorne present "Little Nicky" to a Dallas, Texas, resident who paid $50,000 for the kitten.

When San Francisco-based Genetic Savings and Clone announced in December it had sold a cloned kitten to a Texas woman, the public seemed caught between feelings of revulsion and excitement over the idea of cloning the family pet. The Maine Coon cat's genetic replica, dubbed Little Nicky, was not the first cat ever cloned; the company had already cloned four. However, it was the first to be sold commercially, and it will hardly be the last.

Now that cat cloning is a possibility, at least half a dozen companies say they are planning commercial cloning operations. In addition, some companies are focusing on cloning technology rather than producing clones themselves, such as Westport, Conn.-based Aurox. Others, such as Bryan, Texas-based ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies